That is why I believe a JV should be announced as well as ITLD.
But the sequence is my only issue. I believe based upon PPS action so far that a JV followed by ITLD is the better move for shareholders.
JV would out line revenue and partnership terms which if followed by a robust ITLD and hopefully, as speculative as it is wished, an announcement of FDA compassionate use.
If the compassionate use gets announced it would be icing on the cake as this pushes up the timeframe for revenue dollars substantially.
Yes we can only hope and pray but I think mgt is properly incentivized to see it our way as longs.
if up tick I buy another 500k tomorrow
I was down to 377k shares and holding but increased to 877k shares over past week. may accumulate more tomorrow depending upon opening tick.
Hopefully they announce "fast -tracked" for FDA compassionate use like I believe they did in EU, and at the same time release ITLD, then announce JV
I think you are right about new funding but I think they made it clear that smd/amd would be funded by JV and new stem treatments would require more funding?
Please clarify as I thought they specifically said JV on smd/amd exactly for the purpose of funding treatmnet to end point.
Scary but doing the math on EPS is a big number roughly $350 to $525 dollar per share with 32 million OS.
All this is rough calculations and speculation but somebody please check the math as I'm am really uncertain and need some help here as the number looks too big.
Own DD please!!!!!!!!!!!!!!
Best part about this is that the cost to produce and ship stem cells for treatment are less than $100 per dose and a 10,000 sq ft facility can supply the world. factor that in with a 50% partnership taking top line revenue while partner absorbs production costs and we will have a winner. dividing 15 billion by 35 million shares OS is a big market cap. Selling and marketing expenses should be picked up by partner and we should quickly receive insurance reimbursement as it save insurance companies BIG dollars on potential future claims.
Well well looks like our discussion prior to release was directly on point.
No I believe the RS followed by PPS increase will coincide with ITLD but the JV will be announced as the ebb and flow of wall street drives the demand for new shares. If news hits mainstream CNBC, CBS etc... then this should be a really good sign until JV announcement. Depending upon JV partnership terms ACTC could do very well. Keeping fingers crossed and as always this is just speculation but would like to hear responses. Best think I heard in 7 years of owning this thing.
Silence from ACTC is because of positioning of company regarding ITLD and/or possible JV.
If ACTC announces JV, then positive ITLD is a forgone conclusion. Further, if an uplist still remains a corp objective then releasing ITLD prior to JV announcement would likely be better for shareholders PPS.
On the contrary, ACTC could have serious issues in gaining a JV which would leave it blowing in the wind on it's own for cash to complete testing. (I don't believe this is the case as Dr. W would not have signed on)
All speculation and would like others thoughts on sequence of events.
This is kinda like recording a first trust deed but not the note until a CC1 is recorded.
Look we all know Sept is drop dead, but we all know the management team has boo-coo ISO options riding so they are thinking about share price for sure. What's good for the goose is good for the gander so we hope.
The ban on stem cell research by GW really has nothing to do with ACTC's situation because ACTC's business model from the outset should have realized the political environment they were foraging within and made other arrangements to support research and development.
ACTC inept management has been the sole group responsible for prior missteps and no one else can be blamed. For god sakes you sound like Biel blaming the white man for all you troubles but never yourself have you taken responsibility for all the decisions you made to date. This is the issue with ACTC, quite with the excuses and get on with getting on. My advice to ACTC, either get on with living or get on with dying but start taking action of some kind.
I'm just an active observer of the demented society we live in and like to hear responses from folks who should be committed or have their passports revoked.
Not trying to pat myself on the back but SA is regurgitated BS, always #$%$ articles that only tell the tale after everyone already knows or should know if they are true investors and finance literate.
I see sequence as follows:
1) publish ITLD
2) wait for PPS reaction
3) release JV news
4) possibly look at split if even necessary, might not be with 55 billion smd/amd market.
Realize that ACTC is being scrutinized by many regulatory agencies and if they would like to step over the line, then they will pay the price like GR.
Fair enough and I agree.
My point was a cursory explanation of why, in this particular instance, they didn't allow for open questions.
Open questions and their release of encouraging news are two separate items.
Whether their silence throughout CC was warranted is very debatable but I only offer a reason why they may have chosen to be silent, but believe your explanation of preserving buying shareholders.
If they have the goods then they should encourage and educate the shareholders.
Yes I made same point months ago and posted my position on that point. He also has connections in the industry which could be helpful in rolling the ball forward and scoring so well see, hope we are right.
My bet is still long as I think they have the science. My worry is time versus cash burn, science versus competition in stem space, and management execution of strategy to bring value back to shareholders.